Phase
Condition
Alzheimer's Disease
Dementia
Memory Loss
Treatment
N/AClinical Study ID
Ages 60-85 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria:
Men or surgically sterile or post-menopausal women
Healthy as judged by a responsible physician. No clinically significant abnormalityidentified on the medical or lab evaluation.
BMI between 18.5 and 32.0 kg/m2
Exclusion
Exclusion criteria:
A positive pre-study urine screen for drugs of abuse
Abuse of alcohol
Subjects who smoke more than 10 cigarettes or equivalent a day.
Use of prescription drugs as well as herbal and dietary supplements within 7 daysprior to the first dose of study medication, unless in the opinion of the Investigatorand sponsor the medication will not interfere with the study procedures or compromisesubject safety.
Where participation in the study would result in donation of blood in excess of 500mlwithin a 56 day period.
Has a history or presence of gastro-intestinal, hepatic or renal disease or othercondition known to interfere with the absorption, distribution, metabolism orexcretion of drugs.
The subject has received an investigational drug or participated in another researchtrial within 30 days or 5 half-lives, or twice the duration of the biological effectof any drug (whichever is longer) prior to the first dose of current study medication.
Known or suspected history of seizures, including febrile seizures, unexplained recentloss of consciousness or history of significant head trauma with loss ofconsciousness.
Study Design
Connect with a study center
GSK Investigational Site
Evansville, Indiana 47714
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.